Does activated protein C resistance increase the risk of systemic embolism in non rheumatic atrial fibrillation?
- 1 April 1996
- journal article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 26 (2), 243-244
- https://doi.org/10.1111/j.1445-5994.1996.tb00899.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- Premature ischaemic heart disease and the gene for coagulation factor VNature Medicine, 1995
- Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolismBlood, 1995
- Diagnosis of activated protein C resistance (factor V Leiden)The Lancet, 1994
- Aspirin or warfarin for non-rheumatic atrial fibrillation?The Lancet, 1994
- Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study*1The Lancet, 1994
- Survival and recurrence following stroke. The Framingham study.Stroke, 1982